Logo image of NMRD

NEMAURA MEDICAL INC (NMRD) Stock News

NASDAQ:NMRD - Nasdaq - US6404422080 - Common Stock - Currency: USD

0.1053  -0.02 (-17.8%)

After market: 0.12 +0.01 (+13.96%)

NMRD Latest News, Press Relases and Analysis

News Image
a year ago - Benzinga

Alzamend Neuro And 3 Other Stocks Under $3 Insiders Are Buying

$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

Mentions: FBIO ALZN VANI

News Image
a year ago - Nemaura Medical, Inc

Important Update on Listing Status and Strategic Direction

Loughborough, UK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive...

News Image
a year ago - Nemaura Medical, Inc

Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision

Loughborough, UK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear...

News Image
a year ago - Seeking Alpha

Nemaura Medical secures $10M non-dilutive credit facility (NASDAQ:NMRD)

Nemaura Medical secures a $10M credit facility, leading to a 5.1% surge in shares.

News Image
a year ago - Nemaura Medical, Inc

Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth

Loughborough, UK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear...

News Image
a year ago - Nemaura Medical, Inc

Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs

Company CEO to discuss development at 1pm EST on 15th November 2023, at the Sidoti Virtual Investor Conference Loughborough, UK, Nov. 14, 2023 (GLOBE...

News Image
a year ago - Nemaura Medical, Inc

Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update

Loughborough, England, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company...

News Image
2 years ago - Nemaura Medical, Inc

Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.

LOUGHBOROUGH, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused...

News Image
2 years ago - Nemaura Medical, Inc

Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference

Loughborough, England, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and...

News Image
2 years ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!

Mentions: AGRI MBRX LIFW TKAT ...

News Image
2 years ago - Seeking Alpha

Nemaura Medical says compliance regain with Nasdaq rules not expected (NASDAQ:NMRD)

Nemaura Medical (NMRD) said on Thursday that the medical device company does not expect to regain compliance with Nasdaq's listing deficiencies.

News Image
2 years ago - Nemaura Medical, Inc

Nemaura Medical Provides Update on Nasdaq Compliance Status and Process

LOUGHBOROUGH, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused...

News Image
2 years ago - Nemaura Medical, Inc

Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program

LOUGHBOROUGH, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused...

News Image
2 years ago - Nemaura Medical, Inc

Nemaura Medical Announces Participation at HLTH 2023, Las Vegas

LOUGHBOROUGH, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused...

News Image
2 years ago - Nemaura Medical, Inc

Nemaura Medical Completes 100 Patient Study for sugarBEAT® 24-hour Wear and Reports Interim Results

LOUGHBOROUGH, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized diabetes management and metabolic health programs, today announced it has recently completed a 100-patient study across 4 cohorts of 25 diabetic patients for sugarBEAT® and provided interim results.